Business
PharmAust (ASX:PAA) share price soars 7% on positive update
The PharmAust Limited (ASX: PAA) share price is shooting upwards following an update on its antiviral program. In late afternoon trade, the PharmAust share price is trading for 11 cents apiece, up 7.1%.
What did PharmAust announce?
Investors are pushing PharmAust shares higher after taking in the company’s progress on antiviral activity against COVID-19.
In its announcement, PharmAust provided an update on its lead drug candidates as antiviral therapeutics. These include monepantel (MPL) and also monepantel sulfone (MPLS).
The company stated that data from extensive testing at Leiden University Medical Center (LUMC) has demonstrated antiviral…
-
General23 hours agoLambie, hypocrisy, and the misinformation & disinformation bill
-
General23 hours agoAFLW Sunday: Chloe Molloy kicks wonder goal as Zippy Fish stars for Swans
-
General24 hours agoDockers coach Justin Longmuir calls for AFL to issue huge fines over staging
-
Business5 hours agoHow to retire in your 50s with ASX shares